Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emerald Health Therapeutics Inc TBQBF


Primary Symbol: EMHTF

Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and production excellence.


OTCQB:EMHTF - Post by User

Post by vandenpon Mar 10, 2018 1:34pm
200 Views
Post# 27697208

Chris Wagner at Cantech Investment Conference

Chris Wagner at Cantech Investment Conference
Published on Feb 14, 2018
What is unique about Canadian cannabis companies? Chris Wagner from Emerald Health Therapeutics, Mark Zekulin from Canopy Growth Crop, Brad Rogers from CannTrust Inc., and Greg Engel from OrganiGram Holdings Inc., discuss Canada's leadership position in the world of cannabis at the recent Cantech Investment Conference.  Panel moderated by Russell Stanley from Echelon Wealth Partners.


Can Canada Maintain its Leadership Status in the World of Cannabis?
Bullboard Posts